The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
Prevalence and Correlates of Bipolar Spectrum Disorder in the World Mental Health Survey Initiative
Open accessAbstract
CONTEXT: There is limited information on the prevalence and correlates of bipolar spectrum disorder in international population-based studies using common methods. OBJECTIVES: To describe the prevalence, impact, patterns of comorbidity, and patterns of service utilization for bipolar spectrum disorder (BPS) in the World Health Organization World Mental Health Survey Initiative. DESIGN, SETTING, AND PARTICIPANTS: Cross-sectional, face-to-face, household surveys of 61,392 community adults in 11 countries in the Americas, Europe, and Asia assessed with the World Mental Health version of the World Health Organization Composite International Diagnostic Interview, version 3.0, a fully structured, lay-administered psychiatric diagnostic interview. MAIN OUTCOME MEASURES: Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) disorders, severity, and treatment. RESULTS: The aggregate lifetime prevalences were 0.6% for bipolar type I disorder (BP-I), 0.4% for BP-II, 1.4% for subthreshold BP, and 2.4% for BPS. Twelve-month prevalences were 0.4% for BP-I, 0.3% for BP-II, 0.8% for subthreshold BP, and 1.5% for BPS. Severity of both manic and depressive symptoms as well as suicidal behavior increased monotonically from subthreshold BP to BP-I. By contrast, role impairment was similar across BP subtypes. Symptom severity was greater for depressive episodes than manic episodes, with approximately 74.0% of respondents with depression and 50.9% of respondents with mania reporting severe role impairment. Three-quarters of those with BPS met criteria for at least 1 other disorder, with anxiety disorders (particularly panic attacks) being the most common comorbid condition. Less than half of those with lifetime BPS received mental health treatment, particularly in low-income countries, where only 25.2% reported contact with the mental health system. CONCLUSIONS: Despite cross-site variation in the prevalence rates of BPS, the severity, impact, and patterns of comorbidity were remarkably similar internationally. The uniform increases in clinical correlates, suicidal behavior, and comorbidity across each diagnostic category provide evidence for the validity of the concept of BPS. Treatment needs for BPS are often unmet, particularly in low-income countries.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While the prevalence rates for each subtype varied across the nine countries studied, subthreshold BD was the most common at 1.4% (0.8%), followed by BDI at 0.6% (0.4%) and BDII at 0.4% (0.3%).6”
From Canadian Network for Mood and Anxiety Treatments ( CANMAT ) and International Society for Bipolar Disorders ( ISBD ) 2018 guidelines for the management of patients with bipolar disorder (2018) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Worldwide, approximately 43% of patients with BD report suicidal ideation, 21% a plan, and 16% a suicide attempt within the past year.6”
From Canadian Network for Mood and Anxiety Treatments ( CANMAT ) and International Society for Bipolar Disorders ( ISBD ) 2018 guidelines for the management of patients with bipolar disorder (2018) · cites this paper as [6]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The World Mental Health Survey Initiative reported total lifetime (and 12‐month) prevalence estimates of 2.4% (1.5%) across BDI, BDII and subthreshold BD subtypes.”
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Worldwide, approximately 43% of patients with BD report suicidal ideation, 21% a plan, and 16% a suicide attempt within the past year.6”
From Canadian Network for Mood and Anxiety Treatments ( CANMAT ) and International Society for Bipolar Disorders ( ISBD ) 2018 guidelines for the management of patients with bipolar disorder (2018) · cites this paper as [6]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Worldwide, approximately 43% of patients with BD report suicidal ideation, 21% a plan, and 16% a suicide attempt within the past year.6”
From Canadian Network for Mood and Anxiety Treatments ( CANMAT ) and International Society for Bipolar Disorders ( ISBD ) 2018 guidelines for the management of patients with bipolar disorder (2018) · cites this paper as [6]
Experimental — accuracy not yet measured
In the citing paper
“bipolar depression is considerably more persistent than non-bipolar depression,5”
From The Costs of Depression (2012) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Rating Scale for Mania: Reliability, Validity and Sensitivity
Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978) · British Journal of Psychiatry · doi:10.1192/bjp.133.5.429 · Cited by 8,744
The World Health Report 2002 - Reducing Risks, Promoting Healthy Life
Available, N. A. N. (2003) · Education for Health · doi:10.1080/1357628031000116808 · Cited by 6,078
Rush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., Markowitz, J. C., Ninan, P. T., Kornstein, S., Manber, R., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01866-8 · Cited by 3,829
Davenport, Y. B., Adland, M. L., Gold, P. W., & Goodwin, F. K. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92810-1 · Cited by 2,925
Merikangas, K. R., Akiskal, H. S., Angst, J., Greenberg, P. E., Hirschfeld, R. M. A., Petukhova, M., & Kessler, R. C. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.5.543 · Cited by 2,399
Self-citationCross-national epidemiology of major depression and bipolar disorder
Weissman, M. M. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540040037030 · Cited by 2,302
Introduction to Variance Estimation.
King, B. F., & Wolter, K. M. (1987) · Journal of the American Statistical Association · doi:10.2307/2289497 · Cited by 1,377
Prevalence and incidence studies of anxiety disorders: A systematic review of the literature
Somers, J. M., Goldner, E. M., Waraich, P., & Hsu, L. (2006) · The Canadian Journal of Psychiatry · doi:10.1177/070674370605100206 · Cited by 1,114
Assessing Psychiatric Impairment in Primary Care with the Sheehan Disability Scale
Leon, A. C., Olfson, M., Portera, L., Farber, L., & Sheehan, D. V. (1997) · The International Journal of Psychiatry in Medicine · doi:10.2190/t8em-c8yh-373n-1uwd · Cited by 987
Angst, J., Gamma, A., Benazzi, F., Ajdacic‐Gross, V., Eich, D., & Wulf Rössler, A. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00322-1 · Cited by 889
Research works printed but not linked: 4
- [8]Bauer M Pfennig A Epidemiology of bipolar disorders Epilepsia 2005 46 Suppl 4 8 13 15968806
- [12]Pini S de Queiroz V Pagnin D Prevalence and burden of bipolar disorders in European countries Eur Neuropsychopharmacol 2005 8 15 4 425 434 15935623
- [13]Cooper JE Kendell RE Gurland B Sharpe L Copeland JRM Simon R Psychiatric diagnosis in New York and London: A comparative study of mental hospital admissions 1972 London Oxford University Press
- [26]First M Spitzer R Gibbon M Williams J Structured Clinical Interview for DSM-IV Axis I Disorders, Research Version, Non-patient Edition (SCID-I/NP) 2002 New York Biometrics Research, New York State Psychatric Institute
Cited by
Sorted by citations
Items 501–600 of 1,006
Arketamine for bipolar depression: Open-label, dose-escalation, pilot study
Bandeira, I. D., Leal, G. C.-G., Correia‐Melo, F. S., Souza‐Marques, B., Silva, S. S., Lins-Silva, D. H., Mello, R. P., Vieira, F., Dorea-Bandeira, I., Faria-Guimarães, D., et al. (2023) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2023.06.028 · Cited by 36
Takara, K., & Kondo, T. (2015) · Mental Health in Family Medicine · doi:10.25149/1756-8358.1102011 · Cited by 38
Qiu, F., Akiskal, H. S., Kelsoe, J. R., & Greenwood, T. A. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.08.031 · Cited by 35
MacIntosh, B. J., Shirzadi, Z., Scavone, A., Metcalfe, A. W. S., Islam, A. H., Korczak, D. J., & Goldstein, B. I. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.08.060 · Cited by 38
Jochim, J., Rifkin-Zybutz, R. P., Geddes, J. R., & Cipriani, A. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004052.pub2 · Cited by 37
Pinto, J. V., Saraf, G., Frysch, C., Vigo, D., Keramatian, K., Chakrabarty, T., Lam, R. W. M., Kauer‐Sant’Anna, M., & Yatham, L. N. (2019) · The Canadian Journal of Psychiatry · doi:10.1177/0706743719895195 · Cited by 38
Sleep and sleep treatments in bipolar disorder
Kaplan, K. A. (2020) · Current Opinion in Psychology · doi:10.1016/j.copsyc.2020.02.001 · Cited by 39
Lithium and the Interplay Between Telomeres and Mitochondria in Bipolar Disorder
Lundberg, M., Millischer, V., Backlund, L., Martinsson, L., Stenvinkel, P., Sellgren, C. M., Lavebratt, C., & Schalling, M. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.586083 · Cited by 38
Toyoshima, K., Fujii, Y., Mitsui, N., Kako, Y., Asakura, S., Martínez‐Arán, A., Vieta, E., & Kusumi, I. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.04.043 · Cited by 35
Prisco, M. D., Oliva, V., Fico, G., Montejo, L., Possidente, C., Bracco, L., Fortea, L., Anmella, G., Hidalgo‐Mazzei, D., Fornaro, M., et al. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110847 · Cited by 36
Bipolar II disorder: a state‐of‐the‐art review
Berk, M., Corrales, A., Trisno, R., Dodd, S., Yatham, L. N., Vieta, E., McIntyre, R. S., Suppes, T. M., & Agustini, B. (2025) · World Psychiatry · doi:10.1002/wps.21300 · Cited by 43
Psychiatric disorders in patients with multiple sclerosis.
de Cerqueira, A. C. D., de Andrade, P. S., Barreiros, J. M. G., Teixeira, A., & Nardi, A. (2015) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2015.08.001 · Cited by 36
Fibromyalgia and Bipolar Disorder: Emerging Epidemiological Associations and Shared Pathophysiology
Bortolato, B., Berk, M., Maes, M. H. J., McIntyre, R. S., & Carvalho, A. F. (2016) · Current Molecular Medicine · doi:10.2174/1566524016666160126144027 · Cited by 34
O’Donnell, C., Simplicio, M. C. D., Brown, R. E., Holmes, E. A., & Heyes, S. B. (2017) · Cortex · doi:10.1016/j.cortex.2017.08.010 · Cited by 38
Michelini, G., Kitsune, V., Vainieri, I., Hosang, G. M., Brandeis, D., Asherson, P. J., & Kuntsi, J. (2018) · Brain Topography · doi:10.1007/s10548-018-0625-z · Cited by 34
Content overlap analysis of 64 (hypo)mania symptoms among seven common rating scales
Chrobak, A. A., Siwek, M., Dudek, D., & RYBAKOWSKI, J. K. (2018) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1737 · Cited by 34
Reilly-Harrington, N. A., Feig, E. H., & Huffman, J. C. (2018) · Current Obesity Reports · doi:10.1007/s13679-018-0322-y · Cited by 34
Financial difficulties in bipolar disorder part 1: longitudinal relationships with mental health
Richardson, T. H., Jansen, M., & Fitch, C. (2018) · Journal of Mental Health · doi:10.1080/09638237.2018.1521920 · Cited by 34
Risk and protective factors for opioid misuse in American Indian adolescents
Nalven, T., Spillane, N. S., & Schick, M. R. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.107736 · Cited by 34
Hsu, C., Tsai, S., Tseng, P., Liang, C., Vieta, E., Carvalho, A. F., Stubbs, B., Kao, H.-Y., Tu, Y., & Lin, P. (2022) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2022.01.112 · Cited by 34
The Role of Temperament in the Etiopathogenesis of Bipolar Spectrum Illness
Fountoulakis, K. Ν., Gonda, X., Koufaki, I., Hyphantis, T. N., & Cloninger, C. R. (2016) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000077 · Cited by 36
Lobban, F. A., Dodd, A., Sawczuk, A. P., Asar, Ö., Dagnan, D., Diggle, P. J., Griffiths, M., Honary, M., Knowles, D., Long, R., et al. (2017) · Journal of Medical Internet Research · doi:10.2196/jmir.7008 · Cited by 34
Miola, A., Álvarez‐Villalobos, N. A., Ruiz-Hernández, F. G., Filippis, E. D., Veldić, M., Prieto, M. L., Singh, B., Sánchez-Ruiz, J. A., Núñez, N. A., Gardea‐Resendez, M., et al. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.04.068 · Cited by 33
van Enkhuizen, J., Geyer, M. A., Minassian, A., Perry, W., Henry, B. L., & Young, J. W. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.08.008 · Cited by 32
Integrating Bipolar Disorder Management in Primary Care
Kilbourne, A. M., Goodrich, D. E., O’Donnell, A. N., & Miller, C. J. (2012) · Current Psychiatry Reports · doi:10.1007/s11920-012-0325-4 · Cited by 32
Autistic and schizotypal traits and global functioning in bipolar I disorder
Abu-Akel, A. M., Clark, J., Perry, A., Wood, S. J., Forty, L., Craddock, N. J., Jones, I. R., Gordon‐Smith, K., & Jones, L. A. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.09.059 · Cited by 34
Milienne-Petiot, M., Geyer, M. A., Arnt, J., & Young, J. W. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4543-7 · Cited by 35
Findling, R. L., Youngstrom, E. A., Rowles, B. M., Deyling, E. A., Lingler, J., Stansbrey, R. J., McVoy, M. K., Lytle, S., Calabrese, J. R., & McNamara, N. (2017) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2016.0160 · Cited by 33
Abnormal Degree Centrality Associated With Cognitive Dysfunctions in Early Bipolar Disorder
Deng, W., Zhang, B., Zou, W., Zhang, X., Cheng, X., Guan, L., Lin, Y., Lao, G., Ye, B., Li, X., et al. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00140 · Cited by 33
Mitochondrial DNA content and oxidation in bipolar disorder and its role across brain regions
Bodenstein, D. F., Kim, H. K., Brown, N. C., Navaid, B., Young, L. T., & Andreazza, A. C. (2019) · Schizophrenia · doi:10.1038/s41537-019-0089-5 · Cited by 33
Patient fibroblast circadian rhythms predict lithium sensitivity in bipolar disorder
Sanghani, H., Jagannath, A., Humberstone, T., Ebrahimjee, F., Thomas, J. M., Churchill, G. C., Cipriani, A., Attenburrow, M.-J., Perestenko, O. V., Cowley, S. A., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0769-6 · Cited by 35
Lin, Y., Mojtabai, R., Goes, F. S., & Zandi, P. P. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.07.063 · Cited by 34
Cuesta–Frau, D., Schneider, J., Bakštein, E., Vostatek, P., Španiel, F., & Novák, D. (2020) · Entropy · doi:10.3390/e22111243 · Cited by 34
The Importance of Anxiety States in Bipolar Disorder
Goes, F. S. (2015) · Current Psychiatry Reports · doi:10.1007/s11920-014-0540-2 · Cited by 35
Psychotherapy for bipolar disorder
Schöttle, D., Huber, C. G., Bock, T. A., & Meyer, T. D. (2011) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32834b7c5f · Cited by 33
Datto, C., Pottorf, W. J., Feeley, L., LaPorte, S., & Liss, C. (2016) · Annals of General Psychiatry · doi:10.1186/s12991-016-0096-0 · Cited by 32
Valstad, M., Roelfs, D., Slapø, N. B., Timpe, C. M. F., Rai, A., Matziorinis, A. M., Beck, D., Richard, G., Sæther, L. S., Haatveit, B. C., et al. (2021) · Schizophrenia Bulletin · doi:10.1093/schbul/sbab049 · Cited by 31
Fernandez, M. E., Breen, L. J., & Simpson, T. A. (2014) · Qualitative Health Research · doi:10.1177/1049732314538550 · Cited by 32
Stubbs, B., Vancampfort, D., Solmi, M., Veronese, N., & Fornaro, M. (2016) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415623857 · Cited by 32
Li, D., Tseng, P., Stubbs, B., Chu, C., Chang, H.-Y., Vieta, E., Fornaro, M., Carvalho, A. F., Solmi, M., Veronese, N., et al. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.06.023 · Cited by 33
Keshri, N., Nandeesha, H., & Kattimani, S. (2018) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2018.06.011 · Cited by 32
Murasaki, M., Koyama, T., Kanba, S., Takeuchi, M., Shimizu, Y., Arita, E., Kuroishi, K., Takeuchi, M., & Kamei, S. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4977-6 · Cited by 32
Genetic risk for bipolar disorder and psychopathology from childhood to early adulthood
Mistry, S., Escott‐Price, V., Florio, A. D., Smıth, D. J., & Zammit, S. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.12.091 · Cited by 35
Metabolomic Biomarkers in Mental Disorders: Bipolar Disorder and Schizophrenia
Quintero, M., Stanisic, D., Cruz, G., Pontes, J. G. M., Costa, T. B. B. C., & Tasic, L. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-05542-4_14 · Cited by 32
Hindley, G., Stephenson, L., Keene, A. R., Rifkin, L., Gergel, T., & Owen, G. S. (2019) · Wellcome Open Research · doi:10.12688/wellcomeopenres.14989.2 · Cited by 35
Decreased cortical gyrification in patients with bipolar disorder
Choi, K. W., Han, K., Kim, A., Kang, W., Kang, Y., Tae, W., & Ham, B. (2020) · Psychological Medicine · doi:10.1017/s0033291720004079 · Cited by 32
Prevalence of bipolar disorder in multiple sclerosis: a systematic review and meta-analysis
Joseph, B., Nandakumar, A. L., Ahmed, A. T., Gopal, N., Murad, M. H., Frye, M. A., Tobin, W. O., & Singh, B. (2020) · Evidence-Based Mental Health · doi:10.1136/ebmental-2020-300207 · Cited by 33
Kato, T., Baba, K., Guo, W., Chen, Y., & Nosaka, T. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.07.104 · Cited by 32
Association between testosterone levels and mood disorders: A minireview
Zito, S., Nosari, G., Pigoni, A., Moltrasio, C., & Delvecchio, G. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.02.108 · Cited by 32
Rommel, A., Kitsune, G. L., Michelini, G., Hosang, G. M., Asherson, P. J., McLoughlin, G., Brandeis, D., & Kuntsi, J. (2016) · Brain Topography · doi:10.1007/s10548-016-0508-0 · Cited by 32
Family environment and psychopathology in offspring of parents with bipolar disorder
Lau, P., Hawes, D. J., Hunt, C. J., Frankland, A., Roberts, G. M. P., Wright, A., Costa, D. S. J., & Mitchell, P. B. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.09.010 · Cited by 32
de Oliveira, A. T., Marinho, V., Carvalho, V., Magalhães, F. E. X., Rocha, K. D. M., Ayres, C., Teixeira, S. S., Nunes, M. K. G., Bastos, V. H., & Pinto, G. R. (2018) · Bipolar Disorders · doi:10.1111/bdi.12624 · Cited by 32
Preventing youth homelessness: An international review of evidence
Schwan, K., French, D., Gaetz, S., Ward, A. K., Akerman, J., & Redman, M. (2018) · doi:10.54454/20181025 · Cited by 32
Qi, X., Jia, Y., Pan, C., Li, C., Wen, Y. F., Hao, J., Liu, L., Cheng, B., Cheng, S., Yao, Y., et al. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104806 · Cited by 30
Bahji, A., Ermacora, D., Stephenson, C., Hawken, E. R., & Vazquez, G. (2021) · The Canadian Journal of Psychiatry · doi:10.1177/0706743720970857 · Cited by 31
Impaired conflict resolution and vigilance in euthymic bipolar disorder
Marotta, A., Chiaie, R. D., Spagna, A., Bernabei, L., Sciarretta, M., Roca, J., Biondi, M., & Casagrande, M. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.06.026 · Cited by 30
Sex-Specific Urinary Biomarkers for Diagnosing Bipolar Disorder
Chen, J., Huang, H., Zhao, L., Zhou, D.-Z., Yang, Y., Zheng, P., Yang, D., He, P., Zhou, J., Fang, L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115221 · Cited by 31
International Consensus Group on Depression Prevention in Bipolar Disorder
Frye, M. A., Ha, K., Kanba, S., Kato, T., McElroy, S. L., Özerdem, A., Vázquez, G., & Vieta, E. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10123co1c · Cited by 34
Dell’Osso, B. M., Dobrea, C., Cremaschi, L., Buoli, M., Miller, S., Ketter, T. A., & Altamura, A. C. (2016) · CNS Spectrums · doi:10.1017/s1092852915000887 · Cited by 31
Eiring, Ø., Nylenna, M., & Nytrøen, K. (2015) · Patient · doi:10.1007/s40271-015-0128-x · Cited by 29
Recurrence of bipolar disorder during pregnancy: a systematic review
Salim, M., Sharma, V., & Anderson, K. K. (2018) · Archives of Women s Mental Health · doi:10.1007/s00737-018-0831-4 · Cited by 31
Differentially methylated regions in bipolar disorder and suicide
Gaine, M. E., Seifuddin, F., Sabunciyan, S., Lee, R. S., Benke, K. S., Monson, E. T., Zandi, P. P., Potash, J. B., & Willour, V. L. (2019) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32754 · Cited by 30
Masters, G. A., Brenckle, L., Sankaran, P., Person, S. D., Allison, J. J., Simas, T. A. M., Ko, J. Y., Robbins, C. L., Marsh, W., & Byatt, N. (2019) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2019.09.002 · Cited by 33
Gray matter voxel-based morphometry in mania and remission states of children with bipolar disorder
Xiao, Q., Zhong, Y., Jiao, Q., Lu, G., & Su, Y. E. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.02.042 · Cited by 31
Humpston, C. S., Bebbington, P., & Marwaha, S. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.12.151 · Cited by 33
Affective Temperaments and Illness Severity in Patients with Bipolar Disorder
Luciano, M., Steardo, L., Sampogna, G., Caivano, V., Ciampi, C., Vecchio, V. D., Cerbo, A. D., Giallonardo, V., Zinno, F., Fazio, P. D., et al. (2021) · Medicina · doi:10.3390/medicina57010054 · Cited by 32
Wei, J., Zhao, L., Du, Y., Tian, Y., Ni, P., Ni, R., Wang, Y., Ma, X., Hu, X., & Li, T. (2021) · Psychiatry Research · doi:10.1016/j.psychres.2021.113880 · Cited by 30
Stein, D. J., Kazdin, A. E., Ruscio, A. M., Chiu, W. T., Sampson, N. A., Ziobrowski, H. N., Aguilar-Gaxiola, S., Al-Hamzawi, A., Alonso, J., Altwaijri, Y., et al. (2021) · BMC Psychiatry · doi:10.1186/s12888-021-03363-3 · Cited by 31
Self-citationThe uncinate fasciculus in individuals with and at risk for bipolar disorder: A meta-analysis
Xu, E. P., Nguyen, L. T., Hu, R., Stavish, C. M., Leibenluft, E., & Linke, J. O. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.10.045 · Cited by 31
Hunt, A., & Jaeggi, A. V. (2022) · Evolutionary Human Sciences · doi:10.1017/ehs.2022.23 · Cited by 32
Radhu, N., Ravindran, L. N., LEVINSON, A. J., & Daskalakis, Z. J. (2012) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.120003 · Cited by 34
Bipolar II disorder in patients with a current diagnosis of recurrent depression
Mosolov, S. N., Ushkalova, A., Kostukova, E. G., Shafarenko, A., Alfimov, P., Борисовна, К. А., & Angst, J. (2014) · Bipolar Disorders · doi:10.1111/bdi.12192 · Cited by 32
Papmeyer, M., Sussmann, J. E., Hall, J., McKirdy, J. W., Peel, A., Macdonald, A., Lawrie, S. M., Whalley, H. C., & McIntosh, A. M. (2015) · Psychological Medicine · doi:10.1017/s0033291715001324 · Cited by 31
Wu, C., Hsieh, M. H., Tang, C., & Chang, C.-J. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.03.043 · Cited by 30
Age at onset in patients with bipolar I and II disorder: a comparison of large sample studies
Dell’Osso, B. M., Grancini, B. M., Vismara, M. E. M., Cagna, F. D., Maggi, M., Molle, M. F., Cremaschi, L., Miller, S., Ketter, T. A., & Altamura, A. C. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.04.009 · Cited by 33
Šebela, A., Novák, T., Kemlink, D., & Goetz, M. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1361-8 · Cited by 32
Camacho, M., Almeida, S., Moura, A. R., Fernandes, A. B., Ribeiro, G., da Silva, J. A., Barahona-Corrêa, B., & Oliveira-Maia, A. J. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00527 · Cited by 30
Brancati, G. E., Nunes, A., Scott, K., O’Donovan, C., Cervantes, P., Grof, P., & Alda, M. (2023) · International Journal of Bipolar Disorders · doi:10.1186/s40345-023-00304-9 · Cited by 36
Filho, A. J. M. C., Eyres, C., Blöbaum, L., Landwehr, A., & Tremblay, M. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16098 · Cited by 33
Pharmacogenomics of Bipolar Disorder
Severino, G., Squassina, A., Costa, M. F., Pisanu, C., Calza, S., Alda, M., Zompo, M. D., & Manchia, M. (2013) · Pharmacogenomics · doi:10.2217/pgs.13.51 · Cited by 30
Frye, M. A., Amchin, J., Bauer, M., Adler, C. M., Yang, R., & Ketter, T. A. (2015) · International Journal of Bipolar Disorders · doi:10.1186/s40345-015-0034-0 · Cited by 30
Fellinger, M., Waldhoer, T., Blüml, V., Williams, N., & Vyssoki, B. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.08.007 · Cited by 30
Thiebaut, S., Godart, N. T., Radon, L., Courtet, P., & Guillaume, S. (2018) · L Encéphale · doi:10.1016/j.encep.2018.06.001 · Cited by 30
Atoum, M., Al-Hussami, M. O., & Rayan, A. (2018) · Journal of Child and Adolescent Psychiatric Nursing · doi:10.1111/jcap.12211 · Cited by 30
Sharma, V., Sharma, P., & Sharma, S. (2020) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2020.1743684 · Cited by 31
Wang, D., Li, H., Du, X., Zhou, J., Liu, Y., Ren, H., Yang, X., Zhang, G., & Chen, X. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.514658 · Cited by 33
Teng, Z., Wang, L., Li, S., Tan, Y., Qiu, Y., Wu, C., Jin, K., Chen, J., Huang, J., Tang, H., et al. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.06.018 · Cited by 31
Gut microbial signatures and differences in bipolar disorder and schizophrenia of emerging adulthood
Chen, Y., Zhou, C., Yu, H., Wu, W., Wang, Y., Liu, L., Guang-tao, H., Baojuan Li, A., Peng, Z., & Wang, H. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14044 · Cited by 29
Suppes, T. M., Durgam, S., Kozauer, S. G., Chen, R., Lakkis, H. D., Davis, R. E., Satlin, A., Vanover, K. E., Mates, S. L., McIntyre, R. S., et al. (2023) · Bipolar Disorders · doi:10.1111/bdi.13310 · Cited by 32
Balasubramanian, D., Deng, A. X., Doudney, K., Hampton, M. B., & Kennedy, M. A. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.06.018 · Cited by 31
Evolutionary origin of bipolar disorder-revised: EOBD-R
Sherman, J. A. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.10.005 · Cited by 30
Alcohol use disorders are associated with increased affective lability in bipolar disorder
Lagerberg, T. V., Aminoff, S. R., Aas, M., Bjella, T. D., Henry, C., Leboyer, M., Pedersen, G., Bellivier, F., Icick, R., Andreassen, O. A., et al. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.09.062 · Cited by 34
Ryles, F., Meyer, T. D., Adán-Manes, J., MacMillan, I., & Scott, J. L. (2017) · International Journal of Bipolar Disorders · doi:10.1186/s40345-017-0071-y · Cited by 30
Cardoso, T. D. A., Kochhar, S., Torous, J. B., & Morton, E. E. (2024) · JMIR Mental Health · doi:10.2196/58631 · Cited by 36
Leiz, M., Pfeuffer, N., Rehner, L., Stentzel, U., & van den Berg, N. (2022) · Patient Preference and Adherence · doi:10.2147/ppa.s388106 · Cited by 29
Kong, L., Wang, H., Yan, N., Xu, C., Chen, Y., Zeng, Y., Guo, X., Lü, J., & Hu, S. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102581 · Cited by 29
The Association Among Bipolar Disorder, Mitochondrial Dysfunction, and Reactive Oxygen Species
Kageyama, Y., Okura, S., Sukigara, A., Matsunaga, A., Maekubo, K., Oue, T., Ishihara, K., Deguchi, Y., & Inoue, K. (2025) · Biomolecules · doi:10.3390/biom15030383 · Cited by 34
Parker, G. B., & Fletcher, K. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.10.006 · Cited by 29
Suppes, T. M., Ketter, T. A., Gwizdowski, I. S., Dennehy, E. B., Hill, S. J., Fischer, E. G., Snow, D. E., Gonzalez, R., Sureddi, S., Shivakumar, G., et al. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.02.031 · Cited by 29
Steinacher, A., & Wright, K. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063345 · Cited by 31
Metadata
- Authors
- Merikangas, K. R., Jin, R., He, J.-P., Kessler, R. C., Lee, S., Sampson, N. A., Viana, M. C., Andrade, L. H., Hu, C., Karam, E. G., Ladea, M., Medina-Mora, M. E., Ono, Y., Posada-Villa, J., Sagar, R., Wells, J. E., & Zarkov, Z.
- Affiliations
- National Institute of Mental Health (US)
- Harvard University (US)
- Chinese University of Hong Kong (HK)
- Universidade de São Paulo (BR)
- Shenzhen KangNing Hospital (CN)
- University of Balamand (LB)
- Carol Davila University of Medicine and Pharmacy (RO)
- Keio University (JP)
- All India Institute of Medical Sciences (IN)
- ORCID
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 2011-03-07
- Volume
- 68
- Issue
- 3
- Pages
- 241
- ISSN
- 0003-990X (ISSN-L)
- PMC
- PMC3486639
- OpenAlex
- W1984344128
- Cited by
- 2,627
- References
- 41
- Citations by year
- 2026: 135 · 2025: 212 · 2024: 191 · 2023: 190 · 2022: 232 · 2021: 231 · 2020: 210 · 2019: 219 · 2018: 173 · 2017: 179 · 2016: 162 · 2015: 142 · 2014: 126 · 2013: 111 · 2012: 80
- FWCI
- 76.17
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Archives of General Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Scientific Electronic Library Online (São Paulo Research Foundation, Latin American and Caribbean Center on Health Sciences Information, Conselho Nacional de Desenvolvimento Científico e Tecnológico) (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5r13mh066849-04, 5r01mh069864-04, 5r01mh070884-05)
- National Institute of Mental Health (R13-MH-066849, R01‐MH070884, U01-MH-60220, U01MH060220, R01‐MH069864)
- National Institute on Drug Abuse (K05DA015799, R01DA016558)
- Fogarty International Center (R03TW006481)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Social Sciences › Psychology › Clinical Psychology › Personality Disorders and Psychopathology
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- bipolar spectrum disorders, bipolar I disorder, bipolar II disorder, prevalence, comorbidities, anxiety disorders, panic attacks, suicidal behavior, symptom severity, role impairment, mental health service utilization, treatment needs, low-income countries, cross-national comparison
- MeSH terms
- Adolescent, Adult, Bipolar Disorder, Cross-Sectional Studies, Cross-Cultural Comparison, Depressive Disorder, Major, Major Depressive Disorder, Female, Health Surveys, Humans, Male, Mental Health Services, Middle Aged, Sex Factors, Socioeconomic Factors, Suicide, Attempted, Utilization Review, World Health Organization, Comorbidity, Age of Onset, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
